Gemcitabine resistance in pancreatic cancer: Picking the key players

Michael P. Kim; Gary E. Gallick

doi:10.1158/1078-0432.CCR-07-2247

Gemcitabine resistance in pancreatic cancer: Picking the key players

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1284-1285
Number of pages	2
Journal	Clinical Cancer Research
Volume	14
Issue number	5
DOIs	https://doi.org/10.1158/1078-0432.CCR-07-2247
State	Published - Mar 1 2008

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-07-2247

Cite this

@article{5c1ea5df6a194af3a952af9d420b0bdd,

title = "Gemcitabine resistance in pancreatic cancer: Picking the key players",

author = "Kim, {Michael P.} and Gallick, {Gary E.}",

year = "2008",

month = mar,

day = "1",

doi = "10.1158/1078-0432.CCR-07-2247",

language = "English (US)",

volume = "14",

pages = "1284--1285",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

TY - JOUR

T1 - Gemcitabine resistance in pancreatic cancer

T2 - Picking the key players

AU - Kim, Michael P.

AU - Gallick, Gary E.

PY - 2008/3/1

Y1 - 2008/3/1

UR - http://www.scopus.com/inward/record.url?scp=40949143108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949143108&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-07-2247

DO - 10.1158/1078-0432.CCR-07-2247

M3 - Editorial

C2 - 18316544

AN - SCOPUS:40949143108

SN - 1078-0432

VL - 14

SP - 1284

EP - 1285

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 5

ER -

Gemcitabine resistance in pancreatic cancer: Picking the key players

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this